You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced soft-tissue sarcoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunotherapy and Targeted Therapy for Advanced Soft Tissue

Recruiting
  • Advanced Soft Tissue Sarcoma
    • Beijing, Beijing, China
      Department of Medical Oncology, Peking Union Medical College Hos
    Sep 25, 2023

    Advanced Soft-tissue Sarcoma Trial in Shenzhen (NY-ESO-1 TCR-T)

    Recruiting
    • Advanced Soft-tissue Sarcoma
    • NY-ESO-1 TCR-T
    • Shenzhen, Guangdong, China
      Li Yu
    Nov 17, 2022

    Soft Tissue Sarcoma Trial (Cadonilimab)

    Not yet recruiting
    • Soft Tissue Sarcoma
    • Cadonilimab
    • (no location specified)
    Dec 9, 2022

    Efficacy and Safety of Surufatinib Combined With Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma

    Not yet recruiting
    • Efficacy and Safety of Surufatinib Combined With Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma Patients
    • Surufatinib + envafolimab
    • (no location specified)
    Feb 1, 2023

    Soft Tissue Sarcoma Adult Trial (Surufatinib)

    Not yet recruiting
    • Soft Tissue Sarcoma Adult
    • (no location specified)
    Oct 29, 2023

    Advanced Soft-tissue Sarcoma Trial (Lurbinectedin)

    Not yet recruiting
    • Advanced Soft-tissue Sarcoma
    • (no location specified)
    May 26, 2023

    Sarcoma Trial in Guangzhou (chidamide and toripalimab)

    Recruiting
    • Sarcoma
    • chidamide and toripalimab
    • Guangzhou, Guangdong, China
      Sun Yat-Sen Univerisity
    Sep 4, 2022

    Advanced Soft-tissue Sarcoma Trial (LB-100 plus Doxorrubicin, Doxorubicin)

    Not yet recruiting
    • Advanced Soft-tissue Sarcoma
    • (no location specified)
    Apr 11, 2023

    Soft Tissue Sarcoma Adult, Angiosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in Denmark, Norway, Sweden (Propranolol,

    Recruiting
    • Soft Tissue Sarcoma Adult
    • +2 more
    • Aarhus, Denmark
    • +3 more
    Jul 23, 2023

    Refractory Soft Tissue Sarcomas Trial run by the NCI (Cabozantinib)

    Active, not recruiting
    Has Results
    • Refractory Soft Tissue Sarcomas
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 5, 2022

    Advanced Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Seattle

    Recruiting
    • Advanced Soft Tissue Sarcoma
    • +2 more
    • Nanoparticle Albumin-Bound Rapamycin
    • Pazopanib hydrochloride
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 16, 2022

    Leiomyosarcoma, Liposarcoma, Soft Tissue Sarcoma Adult Trial in Taipei (Eribulin, Lenvatinib)

    Active, not recruiting
    • Leiomyosarcoma
    • +3 more
    • Taipei, Taiwan
    • +1 more
    Dec 27, 2022

    Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in Toulouse (Doxorubicin, Cyclophosphamide)

    Recruiting
    • Advanced Soft-tissue Sarcoma
    • Metastatic Soft-tissue Sarcoma
    • Toulouse, France
      Institut Claudius Reagaud-IUCT Oncopôle
    Oct 6, 2022

    Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Santa Monica (Trabectedin, Ipilimumab, Nivolumab)

    Recruiting
    • Advanced Soft Tissue Sarcoma
    • Metastatic Soft Tissue Sarcoma
    • Santa Monica, California
      Sarcoma Oncology Research Center
    May 4, 2022

    Metastatic Soft Tissue Sarcoma, Advanced Soft Tissue Sarcoma Trial in Aurora (doxorubicin with AGEN1884 and AGEN2034)

    Recruiting
    • Metastatic Soft Tissue Sarcoma
    • Advanced Soft Tissue Sarcoma
    • doxorubicin with AGEN1884 and AGEN2034
    • Aurora, Colorado
      University of Colorado Hospital
    Jan 4, 2023

    Soft Tissue Sarcoma Trial in Switzerland (Nab-Paclitaxel, gemcitabine)

    Terminated
    • Soft Tissue Sarcoma
    • Basel, Switzerland
    • +7 more
    Sep 27, 2022

    Sarcoma Trial in Seoul (Durvalumab+doxorubicin cobination)

    Active, not recruiting
    • Sarcoma
    • Durvalumab+doxorubicin cobination
    • Seoul, Korea, Republic of
      Severance Hospital, Yonsei University Health System
    May 30, 2022

    Advanced Soft-tissue Sarcoma Trial in Nicosia, Amman (Doxorubicin, Cyclophosphamide Oral Product, Prednisolone)

    Recruiting
    • Advanced Soft-tissue Sarcoma
    • Nicosia, Cyprus
    • +1 more
    Jul 1, 2022

    Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

    Active, not recruiting
    • Advanced Soft Tissue Sarcoma
    • +26 more
    • Doxorubicin Hydrochloride
    • +3 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jan 6, 2023

    Soft Tissue Sarcoma Trial in Stanford (Ipilimumab, Cryoablation, Nivolumab)

    Active, not recruiting
    • Soft Tissue Sarcoma
    • Stanford, California
      Stanford Medical Center
    Feb 2, 2022

    Sarcoma,Soft Tissue Trial in Spain (Selinexor 20 MG, Gemcitabine)

    Recruiting
    • Sarcoma,Soft Tissue
    • Tenerife, Canarias, Spain
    • +10 more
    Oct 27, 2023

    Locally Advanced Soft Tissue Sarcoma, Recurrent Soft Tissue Sarcoma Trial in Barcelona, Madrid, Valencia (CEB-01 membrane loaded

    Recruiting
    • Locally Advanced Soft Tissue Sarcoma
    • Recurrent Soft Tissue Sarcoma
    • CEB-01 membrane loaded with SN-38
    • Barcelona, Cataluña, Spain
    • +4 more
    Jul 26, 2022

    Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle

    Recruiting
    • Metastatic Leiomyosarcoma
    • +17 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 13, 2022

    Sarcoma,Soft Tissue, Brachytherapy, Poly(ADP-ribose) Polymerase Inhibitors Trial in Guangzhou (Fluzoparib, Radioactive particle

    Recruiting
    • Sarcoma,Soft Tissue
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    May 30, 2023

    Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma Trial (fruquintinib, Envafolimab)

    Not yet recruiting
    • Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma
    • (no location specified)
    Jul 10, 2023